Pfizer moves forward with once-daily version of weight loss pill after setbacks
The company plans to conduct studies in the second half of the year evaluating multiple doses of the drug. Source
Read MoreThe company plans to conduct studies in the second half of the year evaluating multiple doses of the drug. Source
Read MoreTema ETFs is behind the GLP-1, Obesity & Cardiometabolic ETF (HRTS), which is up 26% since its inception last November.
Read MoreThese are the stocks posting the largest moves in midday trading. Source link
Read MoreNovo Nordisk investors appeared unperturbed Thursday by a critical Harvard report that linked weight loss drugs to a rare eye
Read MoreDrugmakers showed off data on weight loss and diabetes drugs. Also, Oracle announced the general availability of AI documentation assistant
Read MoreHere are the most important news items that investors need to start their trading day. Source link
Read MoreNovo Nordisk said Tuesday that its Wegovy weight loss treatment has been approved in China for long-term weight management. Source
Read MoreThe new plant in Clayton, North Carolina, will be responsible for filling and packaging syringes and injection pens for Wegovy,
Read MoreThe Danish company is testing a rival to drugs such as Ozempic and Wegovy which it says may deliver a
Read More